Author:
Souza Renan P.,Romano Silva Marco A.,Kennedy James L.
Reference91 articles.
1. Allison, D.B. & Casey, D.E. (2001) Antipsychotic-induced weight gain: a review of the literature. Journal of Clinical Psychiatry 62: 22–31
2. Arolt, V., Lencer, R., Nolte, A., Muller-Myhsok, B., Purmann, S., Schurmann, M., Leutelt, J., Pinnow, M., & Schwinger, E. (1996) Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. American Journal of Medical Genetics 67: 564–579
3. Arranz, M.J., Dawson, E., Shaikh, S., Sham, P., Sharma, T., Aitchison, K., Crocq, M.A., Gill, M., Kerwin, R., & Collier, D.A. (1995) Cytochrome P4502D6 genotype does not determine response to clozapine. British Journal of Clinical Pharmacology 39: 417–420
4. Arranz, M.J., Collier, D.A., Munro, J., Sham, P., Kirov, G., Sodhi, M., Roberts, G., Price, J., & Kerwin, R.W. (1996) Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neuroscience Letters 217: 177–178
5. Arranz, M.J., Munro, J., Sham, P., Kirov, G., Murray, R.M., Collier, D.A., & Kerwin, R.W. (1998a) Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophrenia Research 32: 93–99